Corrigendum: Editorial: Mechanistic insight and therapeutic potential for the management of non-alcoholic steatohepatitis (NASH)

Corrigendum: Editorial: Mechanistic insight and therapeutic potential for the management of non-alcoholic steatohepatitis (NASH)

Saved in:

Bibliographic Details
Main Authors:	Umashanker Navik, Amit Khurana, Jasvinder Singh Bhatti
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Endocrinology
Subjects:	non-alcoholic steatohepatitis (NASH) genistein yes-associated Protein (YAP) liver enzyme markers glucose-to-albumin ratio
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1528628/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immune and Inflammatory Pathways in Non-Alcoholic Steatohepatitis (NASH). An update
by: Sorina Cezara Coste, et al.
Published: (2019-05-01)

Sulforaphane ameliorates non-alcoholic steatohepatitis by KLF4-mediated macrophage M2 polarization
by: Xianghui Huang, et al.
Published: (2024-09-01)

Exosomal novel-miRNA-126 mediates vascular endothelial dysfunction by targeting AhR-NLRP3 pathway in nonalcoholic steatohepatitis
by: Qiuhe Chen, et al.
Published: (2025-03-01)

Application of ursodeoxycholic acid at non-alcoholic and alcohol-induced steatohepatitis
by: Ye. A. Fedos’ina, et al.
Published: (2010-06-01)

Impact of Black Pepper (Piper nigrum) Powder on Lipid Profile Parameters Among Subjects with Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Beenish, et al.
Published: (2025-01-01)

Hepatocentric approach to achieving compensation of diabetes mellitus in people with non-alcoholic steatohepatitis
by: N.M. Protas, et al.
Published: (2024-09-01)

Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis
by: D. V. Garbuzenko
Published: (2022-01-01)

Changes in direct markers of liver fibrosis in patients with steatohepatitis non-alcoholic and alcoholic origin on the background of obesity and pathology of the biliary tract
by: A. Yu. Filippova
Published: (2017-04-01)

Two faces of the same coin non alcoholic fatty liver disease; with and without diabetes: Comparative clinico pathological analysis: A cross sectional observational study
by: Syed Mushfiq, et al.
Published: (2025-01-01)

Ductular reaction in alcoholic steatohepatitis, nonalcoholic steatohepatitis and hepatitis C virus infection (immunohistochemical study)
by: O. M. Gavrilyuk
Published: (2014-04-01)

Nonobese mice with nonalcoholic steatohepatitis fed on a choline‐deficient, l‐amino acid‐defined, high‐fat diet exhibit alterations in signaling pathways
by: Noriko Suzuki‐Kemuriyama, et al.
Published: (2021-11-01)

NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL
by: D. V. Blinov
Published: (2015-12-01)

PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN REPUBLIC OF BASHKORTOSTAN (REGIONAL RESULTS OF DIREG 2 STUDY)
by: D. Kh. Kalimullina, et al.
Published: (2017-03-01)

EPIDEMIOLOGICAL FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE IN NOVOSIBIRSK (SIBERIAN FEDERAL DISTRICT): REGIONAL DATA OF OPEN MULTICENTER PROSPECTIVE STUDY DIREG 2
by: V. V. Tsukanov, et al.
Published: (2016-09-01)

Gut microbiome in non-alcoholic fatty liver disease
by: Anastasios Mpountouridis, et al.
Published: (2025-01-01)

Quantitative longitudinal investigation of non-alcoholic steatohepatitis in mice by photoacoustic microscopy
by: Jianshuang Wei, et al.
Published: (2025-08-01)

A Novel GLP-1 and FGF21 Fusion Protein for the Treatment of Non-alcoholic Steatohepatitis (NASH)
by: Zhipeng Zhang, et al.
Published: (2025-04-01)

Prevalence of non-alcoholic fatty liver disease in out-patients of the Russian Federation: DIREG 2 study results
by: V. T. Ivashkin, et al.
Published: (2015-12-01)

Aloperin improves liver non-alcoholic steatohepatitis in vitro and in vivo
by: Zhongsheng Guo, et al.
Published: (2020-05-01)

SMYD2 inhibitors have no effect in improving non-alcoholic steatohepatitis in mice
by: Lanzexin Yang, et al.
Published: (2025-06-01)

Comprehensive treatment of patients with type 2 diabetes, complicated by diabetic kidney disease, with concomitant non-alcoholic steatohepatitis
by: Z.Ya. Kotsiubiichuk, et al.
Published: (2025-04-01)

Steatohepatitis in Children with Obesity
by: Alexander A. Zvyagin, et al.
Published: (2021-08-01)

SENSITIVITY AND SPECIFICITY OF VECTORCARDIOGRAPHY IN DIAGNOSTICS OF ACUTE MYOCARDIAL INFARCTION COMORBID WITH LIVER STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS
by: I. E. Belaya, et al.
Published: (2015-12-01)

Antifibrotic therapies for metabolic dysfunction-associated steatotic liver diseaseKeypoints
by: Robert F. Schwabe, et al.
Published: (2025-08-01)

Deposition features of heterovalent iron (Fe2 + and Fe3 +) in the liver in alcoholic and nonalcoholic steatohepatitis
by: V. A. Tumanskiy, et al.
Published: (2015-12-01)

Identification of biomarkers between coronary artery disease and non-alcoholic steatohepatitis: a combination of bioinformatics and machine learning
by: Yihong Lin, et al.
Published: (2025-07-01)

1,25-dihydroxyvitamin D3 improves non-alcoholic steatohepatitis phenotype in a diet-induced rat model
by: Mei Liu, et al.
Published: (2025-03-01)

Correction of the clinical course of non-alcoholic steatohepatitis and diabetic kidney disease in patients with type 2 diabetes
by: Z.Ya. Kotsiubiichuk, et al.
Published: (2024-10-01)

Minimal Hepatic Encephalopathy in Patients with Alcohol Related and Non-alcoholic Steatohepatitis Related Cirrhosis by Psychometric Hepatic Cephalopathy Score and Critical Flicker Frequency
by: Nitin Jagtap, et al.
Published: (2021-03-01)

Experimental murine non-alcoholic steatohepatitis is associated with behavioural, cognitive, and peripheral neuronal dysfunction
by: V. A. Prikhodko, et al.
Published: (2025-03-01)

A systematic review and meta-analysis of efruxifermin’s efficacy in improving liver fibrosis in patients with NASH/MASH
by: Shuzhai Li, et al.
Published: (2025-05-01)

Ultrasound-driven ROS-scavenging nanobubbles for synergistic NASH treatment via FXR activation
by: Jianru Lin, et al.
Published: (2025-07-01)

THE PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN OUTPATIENTS IN THE FAR EAST FEDERAL DISTRICT
by: V. A. Nevzorova, et al.
Published: (2017-05-01)

Mesenteric panniculitis associated with non-alcoholic fatty liver disease: a case series
by: Mehreen Siyal, et al.
Published: (2024-04-01)

Changes in rat liver fatty acid profile in experimental non-alcoholic steatohepatitis
by: E. B. Shustov, et al.
Published: (2021-12-01)

Identification of FDFT1 and PGRMC1 as New Biomarkers in Nonalcoholic Steatohepatitis (NASH)-Related Hepatocellular Carcinoma by Deep Learning
by: Liu Q, et al.
Published: (2025-04-01)

YAP as a potential therapeutic target for myofibroblast formation in asthma
by: Yanrong Guo, et al.
Published: (2025-02-01)

The state of the cytokine profile in pregnant women with non-alcoholic fatty liver disease at the stage of non-alcoholic steatohepatitis with varying degrees of comorbid obesity under the influence of the developed complex therapy program
by: L. V. Bahnii, et al.
Published: (2023-04-01)

Clinical characteristics of patients with hepatic steatosis and non-alcoholic steatohepatitis combined with obesity and disorders of the biliary tract, depending on the body mass index.
by: A. Yu. Filippova
Published: (2016-03-01)

Unveiling Resmetirom: A systematic review and meta‐analysis on its impact on liver function and safety in non‐alcoholic steatohepatitis treatment
by: Hashim Talib Hashim, et al.
Published: (2024-10-01)